Aclaris Therapeutics, Inc.
(ACRS - NASDAQ)
6,17 USD
📋 Profilo Aziendale

Aclaris Therapeutics, Inc., a biopharmaceutical firm operating in the United States, is currently in the clinical development phase, focused on creating novel therapeutic agents for various immune-inflammatory conditions.

|